Ill. scientist dies, possible plague bacteria link

Sep 20, 2009

(AP) -- The University of Chicago Medical Center says the infection that killed a scientist may be connected to bacteria he researched that causes the plague.

A University of Chicago researcher died Sun., Sept. 13, at the Medical Center's Bernard Mitchell Hospital from an infection which may be attributable to a weakened laboratory strain of Yersinia pestis, the bacteria that causes the plague.

The researcher studied the genetics of harmful bacteria, including a weakened strain of Yersinia pestis that lacks the bacteria's harmful components. This strain is not known to cause illness in healthy adults and has been used in some countries as a live-attenuated vaccine to protect against plague. It has been approved by the Centers for Disease Control and Prevention (CDC) for routine laboratory studies. The weakened strain does not require the special safety precautions required for work with virulent strains.

Though there does not appear to be a threat to the public, and no other illness related to this case has been reported, the Medical Center infection control team is working with the Chicago Department of Public Health (CDPH), the Illinois Department of Public Health (IDPH) and the CDC to investigate the case and take all appropriate precautions.

“This death is a tragic loss to our community,” said James L. Madara, MD, Dean of the Biological Sciences Division and Pritzker School of Medicine, and CEO of the Medical Center. “We are all saddened to lose a valued colleague.”

The patient's initial autopsy showed no obvious cause of death except for the presence of bacteria. Routine cultures of the patient's blood grew the weakened strain of Y. pestis. Whether the attenuated strain caused the fatal illness in this researcher remains uncertain. Additional studies to assess the connection are underway.

Nevertheless, once the attenuated strain of Y. pestis was identified on Sept. 18, Medical Center officials immediately notified the CDPH. As a precautionary measure and in cooperation with the CDPH, Medical Center personnel began notification of family, friends, colleagues and health care personnel who may have had contact with the patient.

People exposed to Y. pestis typically develop symptoms within 2 to 10 days. None of the potential contacts has reported illness. The weakened strain is not believed to be dangerous to healthy individuals, but underlying health conditions could potentially increase susceptibility. Anyone who might have been exposed will be offered antibiotics as a precaution.

While rare in the United States, plague remains a significant problem in the developing world, where up to 3,000 cases are reported every year. U.S. cases still occur in parts of California, Colorado, Utah, Arizona, Nevada and New Mexico. The last known case of person-to-person transmission of plague in the United States occurred in 1924.

Provided by University of Chicago

Explore further: Doctors' checklist could help decrease length of COPD patients' hospital stay

Related Stories

Mimic molecules to protect against plague

Jul 04, 2008

Bacteria that cause pneumonic plague can evade our first-line defences, making it difficult for the body to fight infection. In fact, a signature of the plague is the lack of an inflammatory response. Now, scientists have ...

Scientists look at 'syringe' assembly in plague bacteria

Feb 27, 2008

Bacteria that cause the bubonic plague avoid death in our bodies by injecting our cells with immune evasion proteins. Scientists have discovered a new way bacteria build and hold the syringes, according to research published ...

Researchers Uncover a Secret of the Black Death

Sep 18, 2006

Yersinia pestis, the bacteria that causes plague, is a sneaky little intruder with a remarkable ability to evade the body’s immune system. Upon entering an organism, Y. pestis employs a variety of strategies to slip below ...

Recommended for you

Score IDs patients with upper extremity DVT at low risk

5 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

16 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

16 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.